MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,709 | -48.7% | 1,573 | -58.0% | 0.00% | – |
| Q2 2023 | $96,807 | +97.8% | 3,742 | +83.6% | 0.00% | – |
| Q1 2023 | $48,952 | +245.3% | 2,038 | +180.3% | 0.00% | – |
| Q4 2022 | $14,177 | +1.3% | 727 | +7.7% | 0.00% | – |
| Q3 2022 | $14,000 | +27.3% | 675 | +18.8% | 0.00% | – |
| Q2 2022 | $11,000 | -21.4% | 568 | -12.6% | 0.00% | – |
| Q1 2022 | $14,000 | -99.3% | 650 | -99.4% | 0.00% | – |
| Q2 2021 | $1,977,000 | -12.8% | 114,328 | 0.0% | 0.00% | – |
| Q1 2021 | $2,266,000 | -18.5% | 114,328 | -28.2% | 0.00% | – |
| Q4 2020 | $2,780,000 | -32.4% | 159,228 | -25.4% | 0.00% | – |
| Q3 2020 | $4,115,000 | -10.0% | 213,564 | -9.1% | 0.00% | -100.0% |
| Q2 2020 | $4,573,000 | +39.0% | 235,000 | 0.0% | 0.00% | – |
| Q1 2020 | $3,290,000 | – | 235,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |